Sponsor pipeline

Verdiva Bio Dev Limited clinical trial pipeline

Get alerts when Verdiva Bio Dev Limited's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  1. Stopped

    Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance · Obesity or Overweight With Weight-Related Comorbidities

    Trial terminated

    Also in this update: Final enrollment: 8 participants — 7% of the 120 planned; Primary completion date changed from estimate of Nov 30, 2026 to Sep 11, 2026

    Verdiva Bio Dev LimitedPhase 2 NCT07553299 Registry history of NCT07553299 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1

Disease areas by active trials

Get alerts when Verdiva Bio Dev Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free